Perrigo’s Opill receives FDA approval following unanimous support from advisory committees

Experts discuss the most promising growth prospects in the cell and gene landscape

How scientists extracted a treatment for episodic ataxia from traditional Kwakwaka'wakw medicine

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

TUM Researchers create organoid that emulates the development of the human heart

Researchers identify brain pathway – miR483-5p/Pgap2 – that holds promise for future anxiety treatments

Improved mutational understanding may help develop therapeutics against antimicrobial resistance

We interviewed ScaleReady’s Global Commercial Director Josh Ludwig to learn more about manufacturing in the Cell and Gene Industry

Swedish researchers target the brain’s reward system to treat alcohol use disorder

We had the pleasure of video interviewing Vered Caplan, CEO of Orgenesis, at the latest ISCT convention in Paris (2023).